Bronchial artery embolization in life-threatening massive hemoptysis

Area of Science:

• Interventional Pulmonology
• Vascular Radiology
• Respiratory Medicine

Background:

• Massive hemoptysis presents a significant respiratory emergency requiring prompt diagnosis and treatment.
• Optimal management strategies for massive hemoptysis lack universal consensus, with limited large-scale patient data available.
• This study addresses the need for more evidence by reporting outcomes from a series of patients managed with bronchial artery embolization.

Purpose of the Study:

• To evaluate the efficacy and safety of bronchial artery embolization (BAE) in managing massive hemoptysis.
• To identify the common etiologies of massive hemoptysis in the studied Iranian patient cohort.
• To assess the role of computed tomography (CT) in diagnosing the cause and localizing bleeding in hemoptysis patients.

Main Methods:

• A retrospective review of 30 Iranian patients treated for massive hemoptysis using bronchial artery embolization.
• Computed tomography (CT) scans were utilized for etiological assessment and localization of bleeding in most patients.
• Angiography was performed to confirm bleeding sources and guide embolization procedures.

Main Results:

• Tuberculosis (47%), bronchiectasis (17%), and lung cancer/metastasis (13%) were the most frequent causes of hemoptysis.
• CT scan accurately predicted bleeding location in 100% of non-tuberculosis cases and 50% of tuberculosis cases.
• Bronchial artery embolization demonstrated high efficacy in controlling bleeding with a minimal complication rate.

Conclusions:

• Bronchial artery embolization is a highly effective and safe interventional procedure for managing massive hemoptysis.
• The findings support BAE as a primary treatment modality, complementing existing literature.
• CT imaging is a valuable tool for identifying hemoptysis etiologies and guiding treatment decisions.